Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Equity Average (2016 - 2026)

Nutex Health (NUTX) has disclosed Equity Average for 15 consecutive years, with $432.7 million as the latest value for Q1 2026.

  • For Q1 2026, Equity Average rose 95.02% year-over-year to $432.7 million; the TTM value through Mar 2026 reached $432.7 million, up 95.02%, while the annual FY2025 figure was $306.0 million, 128.66% up from the prior year.
  • Equity Average hit $432.7 million in Q1 2026 for Nutex Health, roughly flat from $430.7 million in the prior quarter.
  • Across five years, Equity Average topped out at $432.7 million in Q1 2026 and bottomed at $79.6 million in Q1 2024.
  • Average Equity Average over 5 years is $211.7 million, with a median of $134.2 million recorded in 2024.
  • Year-over-year, Equity Average crashed 70.71% in 2023 and then skyrocketed 378.93% in 2025.
  • Nutex Health's Equity Average stood at $126.4 million in 2022, then fell by 27.23% to $92.0 million in 2023, then soared by 45.81% to $134.2 million in 2024, then skyrocketed by 221.07% to $430.7 million in 2025, then rose by 0.47% to $432.7 million in 2026.
  • According to Business Quant data, Equity Average over the past three periods came in at $432.7 million, $430.7 million, and $387.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.